1-6 of 6
Barbara W Durkacz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

P B S-1086, a “Pan-Rel” Inhibitor, Decreases Viability of Chronic Lymphocytic Leukemia Cells

Susan J Tudhope, BSc, PhD, Evan A Mulligan, BSc, PhD, Jill E Hunter, BSc, PhD, Geoffrey P Summerfield, MD, Scott Marshall, MD, Jonathan Wallis, MD, Helen Marr, Paul Evans, Chris Lowe, Barbara W Durkacz, BSc, PhD, Jie Zhang, PhD, Jeffrey Meshulam, BS, Kathryn Bobb, MS, Elaine Willmore, BSc, PhD
Journal: Blood
Blood (2012) 120 (21): 867.
https://doi.org/10.1182/blood.V120.21.867.867
Published: 2012
Journal Articles

Relationships Between Aberrant Activity of the NF-κB Subunits and Outcome In Chronic Lymphocytic Leukemia: The Dual Role of DNA Damage Sensor Enzymes

Evan A Mulligan, Jill E Hunter, Arabella EG Baird, Sarah Elliott, Geoffrey P Summerfield, Karen Hamlen, Chris Lowe, Jonathan Wallis, Stephany Veuger, Barbara W Durkacz, Elaine Willmore
Journal: Blood
Blood (2010) 116 (21): 3588.
https://doi.org/10.1182/blood.V116.21.3588.3588
Published: 2010
Journal Articles

ATM Mutant Chronic Lymphocytic Leukaemia Cells are Chemosensitized by Inhibition of DNA-Dependent Protein Kinase

Elaine Willmore, BSc, PhD, Ana Skowronska, Evan A Mulligan, PhD, G. Ahmed, Sarah Elliott, PhD, Geoffrey P Summerfield, Karen Hamlen, Chris Lowe, Barbara W Durkacz, Tanja Stankovic
Journal: Blood
Blood (2010) 116 (21): 433.
https://doi.org/10.1182/blood.V116.21.433.433
Published: 2010
Journal Articles

DNA-Dependent Protein Kinase Is a Therapeutic Target in Poor Prognosis B-Cell Chronic Lymphocytic Leukemia

Elaine Willmore, BSc, PhD, Sarah L. Elliott, Clark J. Crawford, Geoffrey Summerfield, Tryfonia Mainou-Fowler, Graham Jackson, Paul Evans, Paula Newton, Duncan Gowans, Barbara W. Durkacz
Journal: Blood
Blood (2008) 112 (11): 382.
https://doi.org/10.1182/blood.V112.11.382.382
Published: 2008
Journal Articles

Targeting DNA-PK and ATM Increases Sensitivity to Chlorambucil and Fludarabine in Chemoresistant and p53-Defective B-CLL Cells.

Elaine Willmore, PhD, Geoffrey P. Summerfield, MD, Tryfonia Mainou-Fowler, PhD, Graham H. Jackson, MD, Anthony Carter, Andrew R. Pettitt, MD, Barbara W. Durkacz, PhD
Journal: Blood
Blood (2006) 108 (11): 523.
https://doi.org/10.1182/blood.V108.11.523.523
Published: 2006
Journal Articles

A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia

Elaine Willmore, Sarah de Caux, Nicola J. Sunter, Michael J. Tilby, Graham H. Jackson, Caroline A. Austin, Barbara W. Durkacz
Journal: Blood
Blood (2004) 103 (12): 4659–4665.
https://doi.org/10.1182/blood-2003-07-2527
Published: 2004